| Date | Title | Description |
| 21.04.2026 | Brain health platform Ivory raises $1 M Seed funding from Draper Associates, others | Brain health platform Ivory has raised $1 million in a seed funding round from Draper Associates, SAGE Venture Fund, MoSJE, IFCI Ventures, and SIDBI. It was also featured on Shark Tank India last year.
The Mumbai-based startup had previousl... |
| 21.07.2025 | Drei Startups verstärken ihre Verwaltungsräte |
Das Zürcher Food-Startup kaisin. kann neu auf das Wissen, die Erfahrungen und Kompetenzen von Bettina Heinzmann im Verwaltungsrat zählen. Heinzmann, Mitgründerin des Women in Retail Switzerland + Friends Netzwerks, bringe breites Fachwisse... |
| 04.01.2024 | Altoida’s study unveils encouraging results for Alzheimer’s Disease assessment | |
| 25.10.2023 | Positive clinical developments for three digital health startups | |
| 12.06.2023 | Key executive hires for seven startups | |
| 23.01.2023 | Startups measuring the brain that you need to know | Companies are using biomarkers to diagnose and treat mental illness and other neurological disorders
Mental illness is considered the silent pandemic that's been overlooked since the start of COVID. The World Health Organization found the g... |
| 08.12.2022 | Daily AI Roundup: Biggest Machine Learning, Robotic And Automation Updates 8th December 2022 | This is our AI Daily Roundup today. We are covering the top updates from around the world. The updates will feature state-of-the-art capabilities in artificial intelligence (AI), Machine Learning, Robotic Process Automation, Fintech, and hu... |
| 07.12.2022 | Altoida Announces Key Hires To Accelerate Development of Digital Phenotypes Platform for Alzheimer’s Disease | Altoida, ., a precision neurology company pioneering non-invasive brain health measurement and neurological disease diagnostics with AI and augmented reality (AR), announced key appointments across clinical affairs, marketing, and operation... |
| 20.09.2022 | Applauses for Swiss Innovators | |
| 01.04.2022 | Additional $14 million for Altoida to advance its neurocognitive assessment platform | |
| 30.03.2022 | SPACs are on the chopping block thanks to the SEC’s latest proposal | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox.
It may be the end of the road for SPACs.
Paid Content How to harness stakeholder trust in trouble... |
| 30.03.2022 | Altoida snags Merck KGaA-led $14M funding round for Alzheimer's diagnostic app | They say good things take time, and Altoida seems to have taken that adage to heart.
Nearly three years after unveiling its initial series A fundraising efforts—which totaled $6.3 million at the time—the Washington, D.C.-based startup is st... |
| 15.09.2021 | New funding to accelerate Alzheimer’s disease diagnostic platform | Based on two decades of global research, Swiss-U.S. company Altoida is developing an artificial intelligence-based device to monitor neurocognitive function in order to predict Alzheimer’s within 12 months before onset. The diagnostic resul... |
| 09.09.2021 | Altoida Receives Investment from Alzheimer’s Drug Discovery Foundation’s Diagnostics Accelerator to Advance Precision Neurology | Digital biomarkers can truly revolutionize our approach to this complex disease by giving us accessible, easy to use, inexpensive and accurate ways to diagnose patients earlier than ever before, even before symptoms appear.
WASHINGTON (PRWE... |
| 03.09.2021 | Altoida Unveils New Brand Identity with Reimagined Logo and Website | Our new identity demonstrates our commitment to innovating in Precision Neurology, adapting to the needs of our global customers, and operating with data as our guide.
WASHINGTON (PRWEB) September 03, 2021
Altoida, Inc., the world’s leading... |
| 06.08.2021 | FDA Breakthrough Designation for Altoida's medtech neurology device | Established in 2016 in Luzern, Altoida is a pioneer in brain health and digital biomarker science. The medtech startup developing a non-invasive software device that measures and monitors neurocognitive function is backed by two decades of ... |
| 05.08.2021 | Altoida Awarded FDA Breakthrough Designation for Development of World’s First Precision Neurology Device for Prediction of Alzheimer's Disease | Logo “This significant milestone enables Altoida to pioneer a new generation of precision neurology devices which leverage artificial intelligence for prediction of neurodegenerative disorders before onset, rather than rely on analysis of s... |
| 09.07.2021 | Altoida Secures Funding and Research Partnership with Eisai Innovation | |
| 12.05.2020 | Altoida Secures Financing from Hikma Ventures | Altoida Inc., a Houston-based predictive digital biomarker company, secured financing from Hikma Ventures, the venture capital arm of Hikma Pharmaceuticals PLC.
The amount of the deal was not disclosed.
The additional financing will be used... |
| 27.04.2020 | SHS Smarter Healthcare Booster Program reveals the winners | Since October 2019, the Swiss Healthcare Startups (SHS) with the support of Engagement Migros and Swissnex Francisco has been looking for the most outstanding companies that would participate in the inaugural Smarter Healthcare Booster Prog... |
| 27.04.2020 | SHS Smarter Healthcare Booster Program reveals the winners | |
| 17.01.2020 | Eight Swiss startups among the finalists of the Hello Tomorrow Challenge | |
| 17.01.2020 | Eight Swiss startups among the finalists of the Hello Tomorrow Challenge | Hello tomorrow is an international startup award that recognizes early-stage startups in 14 tracks. Six Swiss startups are among the 87 selected finalists that will pitch at the Hello Tomorrow Global summit on 12 and 13 March in Paris. The ... |
| 07.11.2019 | Rice Alliance names most promising life science companies at annual forum | Houston hosted an annual meeting of the minds that included thoughtful discussions, presentations, panels, and startup pitches within the life science industry.
The Texas Life Science Forum, organized and hosted by the Rice Alliance and Bio... |
| 08.10.2019 | Le futur de la prévention pour le deuxième InnoPeaks | |
| 31.05.2019 | Altoida Raises $6.3 Million for Early, AI-Test for Alzheimer's Disease | Altoida assesses brain-health as patients perform quick tasks on a smart phone or tablet. The software behind the 10-minute test detects the small errors that signal brain changes years before dementia symptoms become visible. The startup's... |
| 31.05.2019 | Altoida raises $6.3M to provide digital Alzheimer's biomarkers in augmented reality | By observing precisely how a patient interacts with virtual objects and augmented reality, Altoida aims to provide a set of digital biomarkers that can track the health of the brain and spot the signs of Alzheimer’s disease before symptoms ... |
| 31.05.2019 | Altoida Raises $6.3M for Early Detection of Alzheimer’s Using AI & Augmented Reality | Altoida Inc., a digital health company using digital biomarkers to drive better clinical outcomes for brain diseases has raised $6.3M in Series A funding led by M Ventures, the corporate venture capital arm of the science and technology com... |
| 31.05.2019 | Altoida raises $6.3M to provide digital Alzheimer's biomarkers in augmented reality | By observing precisely how a patient interacts with virtual objects and augmented reality, Altoida aims to provide a set of digital biomarkers that can track the health of the brain and spot the signs of Alzheimer’s disease before symptoms ... |
| 31.05.2019 | Foursquare Buys Location Data Company Placed From Snap: Term Sheet | CHANGING LOCATION
Good morning, Term Sheet readers — I’m back!
Paid Content Securing the enterprise without boundaries From ExtraHop
Foursquare plans to merge Placed with its own ad-effectiveness-measurement product and rebrand it as “Place... |
| 31.05.2019 | Digital Health Startup Altoida Raises $6.3M Series A | |
| 30.05.2019 | Altoida Raises $6.3M in Series A Funding | Altoida, Inc., a developer of FDA-cleared and CE Mark-approved medical device and brain health data platform to patients, physicians and researchers around the globe, raised $6.3m in Series A venture capital financing.
The round was led by ... |
| 30.05.2019 | Using augmented reality, Altoida is identifying the likely onset of neurodegenerative diseases | For the past 19 years, Ioannis Tarnanas, the founder and chief scientific officer at Altoida, has been developing virtual and augmented reality tools to offer predictions about the onset of mental illness in older patients.
The company, who... |
| 30.05.2019 | Altoida Raises $6.3M Series A | Altoida Inc. today announced a $6.3 million round of venture capital financing to bring its FDA-cleared and CE Mark-approved medical device and brain health data platform to patients, physicians and researchers around the globe. Led by a te... |
| 30.05.2019 | Alzheimer's detection platform Altoida raises $6.3M in Series A funding | |
| 09.04.2019 | Die Schweiz ist nicht genug | |
| 05.10.2018 | Innovations in the fields of energy, health and food: The winners of the EIT Awards 2018 | Yesterday evening, the European Institute of Innovation & Technology (EIT) rewarded Europe’s top entrepreneurs Simone Accornero (Italy), Ioannis Tamanas (Greece), Bieke Van Gorp (Belgium), Isabel Hoffmann (Canada) and Laura Soucek (Ital... |
| 04.09.2018 | Schweizer Startup-Gründer für europäische EIT Awards nominiert | |
| 11.03.2018 | Ледяной душ, горячая йога, изнуряющие тренировки: как предприниматели повышают продуктивность с помощью «позитивного стресса»... | Предприниматель Захари Рэпп развивает три компании: PhenoMx, SigmaGenetics и Altoida, которые разрабатывают сканер внутренних органов и неинвазивное устройство для внедрения ДНК в клетки. Он работает по 18 часов в сутки, спит 5-7 часов и сн... |
| 30.12.2016 | Fast Start for Polytech Ecosystem Ventures | |
| - | Startup with bold goal to establish digital biomarkers for neurological disease diagnosis wins $25M | Artificial intelligence is being leveraged to solve a variety of healthcare challenges, but its greatest promise remains its potential to detect and diagnose diseases better than humans can.
The latter is being attempted by NeuraLight, an I... |
